Large cohort analysis assessing kidney outcomes by preservation solution, reporting reduced graft survival associated with HTK versus UW. This supports the cross-organ trend that preservation solution selection has downstream consequences and should be aligned with donor risk and ischemia time expectations.
Stewart ZA, et al. Histidine-Tryptophan-Ketoglutarate (HTK) Is Associated with Reduced Graft Survival of Deceased Donor Kidney Transplants. Am J Transplant. 2009;9(5):1048–1054. doi: 10.1111/j.1600-6143.2008.02545.x. PMID: 19298449.
